Results 21 to 30 of about 17,692,958 (217)

HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication. [PDF]

Viruses, 2021
Antisense protein of Human T-cell Leukemia Virus Type 2 (HTLV-2), also called APH-2, negatively regulates the HTLV-2 and helps the virus to maintain latency via scheming the transcription. Despite the remarkable occurrence of HTLV-2/HIV-1 co-infection, the role of APH-2 influencing HIV-1 replication kinetics is poorly understood and needs investigation.
Londhe R, Kulkarni S.
europepmc   +5 more sources

Anti-HTLV-1/2 IgG Antibodies in the Breastmilk of Seropositive Mothers

Microorganisms, 2021
Background: HTLV-1/2 mother-to-child transmission (MTCT) is an important route for the maintenance of HTLV-1/2 within populations and disproportionally contributes to the burden of HTLV-1-associated diseases.
Carolina Rosadas, Timothy Woo, Jana Haddow, Aileen Rowan, Graham P. Taylor   +4 more
doaj   +1 more source

Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors. [PDF]

Retrovirology, 2019
Of the members of the primate T cell lymphotropic virus (PTLV) family, only the human T-cell leukemia virus type-1 (HTLV-1) causes disease in humans-as the etiological agent of adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other auto-inflammatory disorders.
Harrod R.
europepmc   +5 more sources

Fine tuning of the temporal expression of HTLV-1 and HTLV-2 [PDF]

Frontiers in Microbiology, 2013
Human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) are delta retroviruses that share a common overall genetic organization, splicing pattern, and ability to infect and immortalize T-cells in vitro. However, HTLV-1 and HTLV-2 exhibit a clearly distinct pathogenic potential in infected patients. To find clues to the possible viral determinants
Ilaria eCavallari, Francesca eRende, Cecilia eBender, Maria Grazia Romanelli, Donna Mia D'Agostino, Vincenzo eCiminale, Vincenzo eCiminale   +6 more
openaire   +4 more sources

Infección por virus HTLV-1/2 confirmada por serología y detección de provirus en pacientes ecuatorianos de paraparesis espástica tropical

Infectio, 2020
Background: Infection with the Human T-cell lymphotropic virus (HTLV) type 1 and 2 is endemic in South America. There are only a few clinical reports of this retrovirus in patients in Ecuador, without employing virus-isolation methods or viral DNA ...
Carmen Mosquera
doaj   +1 more source

Estimating the number of HTLV-2 infected persons in the world [PDF]

Retrovirology, 2015
The number of HTLV-1 infected persons in the world has recently been estimated to be at least at 5 to 10 million or perhaps higher due to unavailable data (Gessain and Cassar Front Microbiol 2012). We decided to undertake a similar estimation for HTLV-2 infection. A targeted review of the literature revealed HTLV-2 prevalence estimates in blood donors (
Murphy, Edward L, Cassar, Olivier, Gessain, Antoine   +2 more
openaire   +1 more source

Human T-lymphotropic virus 1/2 infection among immigrants and refugees in Central Brazil, an emerging vulnerable population

Frontiers in Public Health, 2023
IntroductionMigratory flows play a significant role in the spread of human T-lymphotropic virus 1/2 (HTLV-1/2). In the last decade, a substantial migration of individuals occurred from Haiti and Venezuela to Brazil.
Thaís Augusto Marinho, Larissa Silva Magalhães, Kamila Cardoso dos Santos, Thaynara Lorrane Silva Martins, Grazielle Rosa da Costa e Silva, Ágabo Macedo da Costa e Silva, Megmar Aparecida dos Santos Carneiro, Karlla Antonieta Amorim Caetano, Sheila Araújo Teles, Regina Maria Bringel Martins   +9 more
doaj   +1 more source

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis [PDF]

, 2011
Background: Human T lymphotropic virus Type 1 (HTLV-1) causes a chronic inflammatory disease of the central nervous system known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM) which resembles chronic spinal forms of multiple ...
Stumpf, M. P. H. (Michael P. H.), Aviva Witkover, Bangham, Charles RM, Kirk, Paul, Taylor, Graham P, Kirk Paul DW, Lewin Alexandra M, Kirk, Paul DW, Bangham Charles RM, Bangham, C. R. M. (Charles R. M.), Taylor, G. P. (Graham P.), Lewin, Alexandra M, Courtney, A, Kirk, PDW, Richardson, Sylvia, Wait Robin, Witkover, A, Lewin, Alexandra M., Alan Courtney, Robin Wait, Graham P Taylor, Courtney Alan, Michael PH Stumpf, Charles RM Bangham, Witkover Aviva, Witkover, Aviva, Wait, R, Paul DW Kirk, Wait, Robin, Richardson, S, Taylor Graham P, Bangham, CRM, Courtney, Alan, Bangham, CR, Richardson Sylvia, Stumpf, MP, Sylvia Richardson, Stumpf, Michael PH, Kirk, PD, Stumpf, MPH, Taylor, GP, Stumpf Michael PH, Alexandra M Lewin, Lewin, AM   +43 more
core   +1 more source

HTLV-2 infection in injection drug users in King County, Washington [PDF]

Scandinavian Journal of Infectious Diseases, 2006
Human T-cell lymphotropic virus type 2 (HTLV-2) is endemic in injection drug users (IDU), and native American populations in the Americas. Transmission is associated with high-risk injection and sexual practices. A cohort of 2561 IDU in King County, Washington completed 2 study visits over 1 y.
Joseph R, Zunt, Ken, Tapia, Hanne, Thiede, Rong, Lee, Holly, Hagan   +4 more
openaire   +2 more sources

Making Visible HTLV Infection in a Non-endemic Area of Argentina

Frontiers in Medicine, 2022
In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered ...
Federico R. Simioli, Maria B. Bouzas, Dana Mijalovsky, Maria V. Pineda, Lilia Mammana, Andrea Mangano, Andrea Mangano, Tomas A. Orduna   +7 more
doaj   +1 more source